ConclusionsIn conclusion, safety markers including kidney function were unchanged throughout the study and not differentially affected by intervention in the two groups, with effcacy outcomes confirming those of previous studies and—most likely—not depending on kidney function. VLCKD is therefore a safe and effective dietary intervention in patients with obesity affected by mild CKD when conducted under medical supervision in a real-life setting, although caution should be taken in screening for a lack of micronutrients and for altered bone metabolism, as well as in accurately monitoring protein consumption at all times.
การแปล กรุณารอสักครู่..
